H.R.1570 - Removing Barriers to Colorectal Cancer Screening Act of 2020116th Congress (2019-2020)
|Sponsor:||Rep. Payne, Donald M., Jr. [D-NJ-10] (Introduced 03/06/2019)|
|Committees:||House - Energy and Commerce; Ways and Means | Senate - Health, Education, Labor, and Pensions|
|Committee Prints:||H.Prt. 116-51|
|Latest Action:||Senate - 12/10/2020 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Passed House
Here are the steps for Status of Legislation:
- Passed House
Summary: H.R.1570 — 116th Congress (2019-2020)All Information (Except Text)
Passed House (12/09/2020)
Removing Barriers to Colorectal Cancer Screening Act of 2020
This bill modifies cost-sharing requirements for colorectal cancer screening tests, and drug manufacturer reporting requirements, under Medicare medical services.
Specifically, the bill waives coinsurance requirements with respect to colorectal cancer screening tests, regardless of the code billed for a resulting diagnosis or procedure. The bill phases in implementation over an eight-year period.
Additionally, manufacturers of covered drugs that do not have rebate agreements under the Medicaid Drug Rebate Program must report similar information as is required under the program, including average sales price, total units, and wholesale acquisition cost. Manufacturers that fail to comply or that report false information are subject to civil penalties.